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Abstract
Focal brain ischemia markedly affects cerebrovascular reactivity. So far, these changes
have mainly been related to alterations in the level of smooth muscle cell function while alter-
ations of the endothelial lining have not yet been studied in detail. We have, therefore, inves-
tigated the effects of ischemia/reperfusion injury on bradykinin (BK)-induced relaxation
since BK is an important mediator of tissue inflammation and affects vascular function in an
endothelium-dependent manner. Focal brain ischemia was induced in rats by endovascular
filament occlusion (2h) of the middle cerebral artery (MCA). After 22h reperfusion, both
MCAs were harvested and the response to BK studied in organ bath experiments. Expres-
sion of the BK receptor subtypes 1 and 2 (B1, B2) was determined by real-time semi-quanti-
tative RT-qPCR methodology, and whole mount immunofluorescence staining was
performed to show the B2 receptor protein expression. In control animals, BK did not induce
significant vasomotor effects despite a functionally intact endothelium and robust expres-
sion of B2 mRNA. After ischemia/reperfusion injury, BK induced a concentration-related sus-
tained relaxation in all arteries studied, more pronounced in the ipsilateral than in the
contralateral MCA. The B2 mRNA was significantly upregulated and the B1 mRNA displayed
de novo expression, again more pronounced ipsi- than contralaterally. Endothelial cells dis-
playing B2 receptor immunofluorescence were observed scattered or clustered in previously
occluded MCAs. Relaxation to BK was mediated by B2 receptor activation, abolished after
endothelium denudation, and largely diminished by blocking nitric oxide (NO) release or sol-
uble guanylyl cyclase activity. Relaxation to BK was partially inhibited by charybdotoxin
(ChTx), but not apamin or iberiotoxin suggesting activation of an endothelium-dependent
hyperpolarization pathway. When the NO-cGMP pathway was blocked, BK induced a tran-
sient relaxation which was suppressed by ChTx. After ischemia/reperfusion injury BK elicits
endothelium-dependent relaxation which was not detectable in control MCAs. This gain of
function is mediated by B2 receptor activation and involves the release of NO and activation
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of an endothelium-dependent hyperpolarization. It goes along with increased B2 mRNA and
protein expression, leaving the functional role of the de novo B1 receptor expression still
open.
Introduction
The presence of kinins, as well as kinin-synthesizing and–destroying enzymes in the brain,
was first described by Hori [1] in rabbits. Based on these and subsequent studies supporting
and extending the initial findings, brain tissue is considered to express a full kallikrein-kinin
system (KKS). The major biologically active component of the KKS, the nonapeptide bradyki-
nin (BK), acts upon two receptor types termed subtype 1 (B1) and subtype 2 (B2) receptor. In
the brain vasculature, BK exerts endothelium-dependent vasodilatation of arteries and arteri-
oles and an increase in capillary permeability eventually leading to (enhancement of) vasogenic
brain edema. In healthy conditions, these effects are mediated by activating the B2 receptor [2]
which is constitutively expressed on the endothelial cells while the expression of the B1 recep-
tor is typically below detection levels.
Despite much research performed in the past, the importance of the B1 and B2 receptors in
vascular dysfunction and tissue damage following a traumatic or ischemic brain insult is still
not fully understood. A major role of the B2 receptor may be derived from studies using selec-
tive receptor antagonists or B2 receptor knock-out mice showing a reduction of the volume of
tissue, a decrease of brain edema, and improvement of neurological outcome in models of
brain trauma [3–6] and ischemia [7–9]. Moreover, in brain trauma patients, application of B2
receptor antagonists proved effective in counteracting the increase in intracranial pressure [10,
11]. However, pharmacological inhibition or knock-out of the B1 receptor has also been
shown to carry therapeutic benefit in a model of ischemic brain damage in mice [12]. Thus,
both B1, as well as B2 receptors, may be of functional importance in KKS activation and media-
tion of BK-induced effects in pathological situations.
Alterations of cerebroarterial reactivity in pathological conditions accompanied by alter-
ations of gene expression have been demonstrated for endothelin-1, angiotensin II, and 5-HT
in models of focal brain ischemia [13–15]. However, these studies have focused on the smooth
muscle cells only, disregarding potential changes in endothelial cells, which play a pivotal role
in the regulation of vascular tone and reactivity. We have, therefore, investigated the alter-
ations of the vasomotor effects of BK following ischemia/reperfusion (I/R) injury in the rat
middle cerebral artery (MCA). Bradykinin was chosen because (i) its vasomotor effect in cere-
bral arteries is endothelium-dependent, and (ii) activation of the KKS is a highly adaptive
inflammatory response following ischemic and traumatic injury with a de novo expression of
the B1 receptor appearing to be a hallmark [16]. Although B1 receptor activation has been
linked to vasomotor activity in peripheral arteries [17], no such data are available yet in cere-
bral arteries.
Our results indicate a tremendous increase in the relaxation-inducing action of BK in rat
MCA following I/R injury. Despite a de novo expression of the B1 receptor mRNA in the vessel
wall, we found no indication of any vasomotor effect. In fact, relaxation mediated by B2 recep-
tor activation was endothelium-dependent and involved release of nitric oxide (NO) and acti-
vation of an endothelium-dependent hyperpolarizing factor (EDHF)-related pathway. The
enhanced vasomotor action went along with a significant upregulation of the B2 receptor on
the level of gene expression and occurrence of a respective immunofluorescent signal in the
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endothelium. To the best of our knowledge, the present study is the first to describe I/R injury-
related alterations of B1 and B2 receptors on the levels of gene expression, protein expression
and vasomotor reactivity in the rat MCA.
Materials and methods
Male Sprague Dawley rats (body weight 300–500 g) from Janvier (Isle St. Genest, France) were
used throughout. All animals were allowed to accommodate for at least one week before exper-
iments were done. Approval of the experimental protocol was obtained from the Federal Ani-
mal Ethics Committee (Regierungspraesidium Karlsruhe). The experiments were performed
in compliance with the relevant laws and institutional guidelines for the care and use of ani-
mals in research according to the Directive 2010/63/EU. This includes all efforts to minimize
pain and stress to the animals and limits to the number of animals used.
Induction of focal ischemia and reperfusion
Focal brain ischemia was induced by the intravascular filament occlusion technique as
described previously [18, 19]. A surgical level of anesthesia was established with isoflurane
(3.0% in a 70:30 air: O2 mixture) delivered through a face mask while spontaneously breathing.
The skull was exposed and a hole created over the right (subsequent ischemic) hemisphere
(1mm caudally / 4 mm laterally from the bregma) leaving the inner bone layer intact. A glass
fiber connected to a laser Doppler flowmetry (LDF) monitor (Moore DRT 4, Axminster,
England) was attached to the hole for continuous recording of perfusion in the area supplied
by the MCA. The animal was then turned into a supine position and the neck opened in the
midline. The carotid bifurcation was identified on the right side and flow through the common
carotid artery transiently blocked. The external carotid artery was ligated and mobilized. A
nylon filament (4–0) coated with an elastomer (Provil novolight, Heraeus Kulzer, Hanau Ger-
many; tip diameter, 430–460 μm) was introduced and advanced into the internal carotid artery
until a sudden drop of the LDF signal indicated MCA occlusion. The filament was fixed to the
external carotid artery, the block of the common carotid artery released and the LDF recording
checked for signs of hemorrhage [20]. Buprenorphine (3 μg / 100 g body weight) was injected
subcutaneously to reduce postoperative pain, the glass fiber was removed, and after closure of
all wounds, the animal was returned to its cage to recover from anesthesia.
The animals were re-anesthetized with isoflurane 100 min after establishing MCA occlu-
sion. The LDF-probe was re-inserted in the skull and the filament removed 2 h after position-
ing. A sharp increase of the LDF signal indicated successful reperfusion. Buprenorphine was
again injected (half the dose given in the first surgical session) and after removal of the LDF
fiber all wounds were closed again. Anesthesia was discontinued and the animal returned to its
cage.
Studies of vasoreactivity
At the end of the 24h observation period, the animals were deeply anesthetized (5% isoflurane
in oxygen) and sacrificed by bleeding from the carotid arteries. The skull was quickly opened
and the brain carefully removed and transferred into a dish containing cold modified Krebs
solution (composition in mM: NaCl, 119; KCl, 3.0; NaH2PO4, 1.2; CaCl2, 1.5; MgCl2, 1.2;
NaHCO3, 15; glucose, 10). Both MCAs were meticulously isolated under a binocular micro-
scope (GZ6, Zeiss, Oberkochem, Germany) and ring segments of approximately 2 mm length
mounted onto 2 stainless steel wires (diameter, 30μm) for measurement of isometric force. In
some experiments endothelium denudation was performed by rubbing the luminal surface of
the segment with an eyelash as described previously [21].
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After mounting, all segments received a 90 min accommodation period with warming of
the bath solution to 37˚C and repeated correction of the resting tension until a stable level of
approximately 2.5 mN was reached. Tension was measured by force transducers (F10, coupled
to TAM-A amplifiers, both from Hugo Sachs, March-Hugstetten, Germany). The signals from
the force detection systems were fed into a computer and continuously recorded using a pur-
pose-built program based on LabView (Munich, Germany) as described previously [22].
After accommodation all segments underwent standard tests to prove (i) the functional
integrity of the contractile apparatus by immersion in Krebs solutions containing increasing
concentrations of K+ (50, 80, and 124 mM; NaCl substituted by KCl in equimolar amounts)
and (ii) the presence or successful removal of the endothelium by cumulative application of
sarafotoxin 6c (10−8 and 10−7 M) following precontraction with the thromboxane A2 receptor
analogue U46619 (3x10-7 M). Sarafotoxin 6c selectively activates the endothelin B receptor
subtype located in endothelial cells resulting in release of NO [23].
The vasomotor effect of BK was studied after precontraction with U46619 (we never
observed contraction when BK was applied upon resting tension). Receptor characterization
was done by incubating ring segments for at least 30 minutes with the selective B1 receptor
antagonist lys-(des-arg9,leu8)-BK (10−5 M) or the selective B2 receptor antagonist Hoe140
(10 -6 M) before application of BK. In addition, we also tested the effect of the selective B1
receptor agonist lys-(des-arg9)-BK (10−12–10−6 M) in precontracted segments. In order to
characterize the mechanisms involved in mediating BK-induced relaxation after I/R injury, we
used blockers of NO release and inhibitors of Ca2+-dependent K+ (KCa) channels. In each case,
the segments were exposed to the blockers for at least 30 minutes before precontraction with
U46619 and application of BK.
Studies of gene expression
Gene expression was studied in individual MCAs. The arteries were carefully cleaned from all
adhering tissue, transferred into cell lysis buffer (RLT buffer [Qiagen, Hilden, Germany],
350 μl plus 3.5 μl mercaptoethanol), and immediately cooled down to -75˚C until further use.
Each MCA underwent mechanical disruption using a motor-driven homogenizer (Homgen,
Schuett Biotec, Goettingen, Germany), shearing of DNA by repeated pushing through a 30G
needle, and extraction of total RNA using a commercially available kit (RNeasyplus, Qiagen).
Concentration and integrity of the total RNA obtained were measured using Picochips read in
a 2100 Bioanalyzer (both from Agilent Technologies, Waldbronn, Germany).
For reverse transcription 10μl total RNA solution obtained from individual arteries was
mixed with 1 μl random hexamers (200 ng/μl) and 1 μl oligo (dT)18 solution (10 μM; both
from Sigma-Aldrich), heated to 70˚ C for 5 min and immediately cooled down on ice. Thereaf-
ter, 8 μl master mix (4 μl 5x RT-buffer; 2 μl dNTP mix [5 mM each], 1 μl RNase Inhibitor
[RNasin1 Plus, 20 U/μl]; all from Promega), 1 μl Sensiscript1 reverse transcriptase [200 U/
μl]; Qiagen) were added and the solution was incubated at 37˚ C for 90 min (PCR Express,
Hybaid Thermo Scientific). The reaction was stopped by increasing to 94˚ C for 10 min.
Gene expression was measured by real-time semi-quantitative real-time PCR (RT-qPCR)
methodology using 1 μl of cDNA solution which was mixed with 8 μl PCR-grade H2O, 10 μl
Absolute™QPCR Mix (Thermo Scientific, Hamburg, Germany), and 1 μl of a probe specific
primer mixture (TaqMan1 Gene expression Assay [20x], Applied Biosystems). We used com-
mercially available hydrolysis probes (TaqMan1, Applied Biosystems, Darmstadt, Germany).
The assay designations (in brackets are given the gene name, the accession number, the respec-
tive assay number, the assay location, and the amplicon length) are elongation factor 1
(EeF1a2, NM_012660.2, #Rn00561973_m1, 1592, 82bp,), B1 receptor (Bdkrb1, NM_030851.1,
Vasomotor effects of bradykinin after I/R injury
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#Rn00578261_m1, 86; 105 bp), and B2 receptor (Bdkrb2, NM_173100.2, #Rn00597384_m1,
209, 75bp,). The amplification protocol consisted of an initial heating period (95˚C for 15
min) followed by 40 amplification cycles (95˚C for 15 sec and 60˚C for 1 min). Experiments
were performed using either a Stratagene MxPro 3005P light cycler (Stratagene Europe,
Amsterdam, The Netherlands) or a StepOne light cycler (Applied Biosystems). In preliminary
studies we confirmed that both systems yielded fully comparable results. Measurements were
done at least in duplicates and the cycle threshold (CT) values averaged to be used for further
analyses.
Immunofluorescence detection of B2 receptor protein expression
Whole mount immunofluorescence microscopy was performed to detect B2 receptor protein
expression in the MCA wall. Arteries were cut along their long axis and immersed in 4% para-
formaldehyde for 10 minutes at room temperature. Subsequently, free-floating staining was
performed in 96 well plates at room temperature unless otherwise stated. The protocol with
washes between the incubation steps consisted of (i) incubation in TritonX100 (1% dissolved
in saline solution PBS for 30 minutes), (ii) immersion in serum free protein block (DAKO
X0909, DAKO, Hamburg, Germany) for 60 minutes, (iii) incubation with a primary antibody
raised against the B2 receptor protein (mouse monoclonal α B2R, sc-136216, Santa Cruz, Hei-
delberg, Germany; dilution, 1:300 overnight at 4˚C), (iv) incubation with the secondary antise-
rum (goat anti mouse IgG, Invitrogen A11004 Alexa Fluor 568, Thermo Fisher Scientific,
Darmstadt, Germany; dilution 1:1000 for 3 h), (v) nuclear counterstaining with 40,6-Diami-
din-2-phenylindol (DAPI, 300 nM), (vi) covering (Roti1-Mount FluorCare HP19.1, Carl
Roth, Karlsruhe, Germany). The segments were examined under a fluorescence microscope
(Z1) equipped with an Axiocam camera (both from Carl Zeiss, Jena, Germany).
Measurement of ischemic brain damage
The volume of ischemic damage was determined based on the high contrast silver nitrate
staining method introduced by Vogel and coworkers [24]. Briefly, serial cryosections of the
brain (thickness, 20 μm; distance 1 mm) were air-dried, immersed in an impregnation solution
for 2 min (composition: 5ml of a 10% silver nitrate solution and 10ml saturated lithium car-
bonate solution were mixed and after dissolving the white precipitate by adding 25% ammonia
drop by drop, 75ml distilled water was added), washed in distilled water (6 x 1 min) and subse-
quently immersed in a developing solution for 3 min (0.3 g hydroquinone, 15 ml acetone and
1.1g trisodium citrate dissolved in 20ml formaldehyde (37%) / 70ml distilled water), washed
again before covering with Eukitt medium (O. Kindler GmbH, Bobingen, Germany). Volu-
metric analysis of the brain damage was performed as described in detail previously [19].
Materials
The chemicals used in the present study along with the suppliers are Bk acetate salt, lys-(des-
arg9)-BK trifluoroacetate salt (B1 receptor agonist), lys-(des-arg
9,leu8)-BK (B1 receptor antago-
nist) and iberiotoxin from Bachem (Heidelberg, Germany), Hoe 140 (Arg-Arg-Pro-Hyp-Gly-
Thi-Ser-Tic-Oic-Arg, B2 receptor antagonist), charybdotoxin (ChTx), N
ω–nitro-l-arginine
(L-NNA), trisodium citrate dihydrate, hydroquinone, and carbolithium from Sigma-Aldrich
(Taufkirchen, Germany); sarafotoxin 6c, U46619 (9,11-Dideoxy-9a,11a-methanoepoxy prosta-
glandin F2a) and ODQ (1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one) from Enzo Life Science
(Lausanne, Switzerland); 7-nitroindazole (7-NI) sodium salt from Santa Cruz Biotechnology
(Heidelberg, Germany); apamin from RBI (Ko¨ln, Germany); NaCl, KCl, MgCl2, NaHCO3, glu-
cose, and 25% ammonia solution from ROTH (Karlsruhe, Germany); NaH2PO4, CaCl2, silver
Vasomotor effects of bradykinin after I/R injury
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nitrate, formaldehyde and acetone from Merck (Darmstadt, Germany); buprenorphine hydro-
chloride (Temgesic™; Essex Pharma, Munich, Germany); isoflurane (Forene™, AbbVie, Lud-
wigshafen, Germany).
Calculations and statistical analyses
In myograph studies relaxation is expressed in percent of precontraction induced by U46619
(300 nM). Levels of gene expression in the MCA wall were determined by means of the ΔCT
method with elongation factor-1 serving as house-keeping gene. Ischemia-induced alterations
of gene expression were determined using the comparative threshold cycle method (ΔΔCT
methodology), and accumulation or depletion was calculated as fold change = 2-ΔΔCT accord-
ing to Schmittgen and Livak [25].
The SigmaPlot software package (vers. 12.5; Systat Software GmbH, Erkrath, Germany) was
employed for statistical analysis and preparation of the graphs. Statistical analysis was done
using unpaired Student’s t-test or if appropriate ANOVA procedure along with the Tukey test
for post-hoc pairwise comparisons. All values are given as mean ±SEM along with the numbers
of observations. In addition, fold changes are given along with the 95% confidence intervals.
Results
A total of 42 rats underwent MCA occlusion. Among these 5 were excluded because of a pre-
mature death. Occlusion of the MCA origin resulted in development of focal ischemic damage
throughout all animals included in the analysis. Hemispheric swelling was 36±2.5% indicating
the presence of marked vasogenic edema. The volume of ischemic damage was 340±16 mm3
(n = 28) after appropriate correction for brain swelling.
Studies in MCAs from control animals
In cerebral arteries obtained from control rats, BK did not induce any significant vasomotor
effect, neither under resting tension conditions nor following precontraction with U46619
(3x10-7 M). However, in each of these segments sarafotoxin 6c induced significant relaxation
(maximum effect, 57±5.2%; n = 25) indicating that the failure of BK to elicit relaxation could
not be ascribed to (functional) damage of the endothelium. Despite the lack of a significant
vasomotor effect we found the B2 message present in all MCA vessels studied by means of RT-
qPCR methodology (see Table 1).
Marked relaxation by BK occurring after transient MCA occlusion goes
along with an upregulation of B1 and B2 receptor gene expression
After 2h of focal ischemia / 22h of recirculation BK induced a pronounced concentration-
related relaxation which was well sustained in all MCA ring segments studied. This was true in
the previously occluded MCA, and it was also true in the contralateral arteries, although at a
significantly lower degree (Fig 1). A stable level of precontraction induced by U46619 (3x10-7
M) was found in time-matched solvent control experiments indicating that the relaxation was
not due to spontaneous loss of tension. Furthermore, relaxation was fully reproducible when
BK was applied repeatedly (Fig 1). Relaxation upon BK also occurred in segments precon-
tracted by immersion in 50 mM K+ Krebs solution, although the maximum value observed (46
±8.5%, n = 8) was considerably smaller than in U46619-precontracted segments.
The relaxation-inducing effect of BK went along with a significant upregulation of the B2
mRNA expression which was more pronounced in the MCAs from the ischemic hemisphere
than in the contralateral arteries. In addition, there was a de novo expression of the B1 mRNA
Vasomotor effects of bradykinin after I/R injury
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in the MCA vessel wall, again somewhat higher in the arteries taken from the ischemic than
from the contralateral hemisphere (Table 1). These changes in gene expression were highly
robust since they were found in all vessels studied.
Table 1. Expression levels of the bradykinin subtype 1receptor (B1) and subtype 2 receptor (B2) mRNA in rat middle cerebral arteries (MCA) obtained under con-
trol conditions and after filament occlusion of the MCA origin (2h occlusion followed by 22h of reperfusion). Indicated are the ΔCT values using elongation factor
(EF)-1 as house-keeping gene as well as the fold up-regulation based upon the ΔΔCT methodology. Given are mean ± SEM ( 4 samples) while the average fold change is
indicated along with the 95% confidence intervals in brackets.
Control 24 h after transient MCA occlusion
MCA ipsilateral MCA contralateral
ΔCT ΔCT fold upregulation ΔCT fold upregulation
B1 mRNA n.d. 0.88±0.42 de novo expression 1.30±0.39 de novo expression






p<0.01 vs. control MCA.
https://doi.org/10.1371/journal.pone.0198553.t001
Fig 1. Concentration-related relaxation induced by bradykinin (BK) of middle cerebral artery (MCA) ring segments
precontracted with U46619 (3x10-7 M). The ring segments were obtained from rats which had undergone a 2h MCA occlusion
followed by 22h of reperfusion. Shown are the results for the right (ischemic) and left (contralateral) MCA. The vasomotor effects
were comparable upon the first and second application of BK in both sides. Solvent indicates time matched solvent control
measurements to check for the stability of precontraction. Given are mean ±SEM based on7 observations.
https://doi.org/10.1371/journal.pone.0198553.g001
Vasomotor effects of bradykinin after I/R injury
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BK-induced relaxation after transient MCA occlusion is mediated by B2
receptor activation: functional and immunofluorescence evidence
In order to characterize the receptor subtype(s) underlying BK-induced relaxation following I/
R injury, specific agonists and antagonist were used. In the ipsilateral MCA, the B1 agonist lys-
(des-arg9)-BK up to 1μM was devoid of any vasomotor effect, both under resting tension con-
ditions as well as in precontracted segments (not shown). Furthermore, BK-induced relaxation
was completely unaffected in the presence of the B1 antagonist lys-(des-arg
9,leu8)-Bk (10−5 M).
In contrast, the selective B2 antagonist Hoe140 (10
−6 M) abrogated the vasomotor effect of BK
suggesting B2 activation to solely account for the relaxation induced by BK following I/R injury
(Fig 2). Comparable effects were observed in ring segments from the contralateral MCA (not
shown).
Whole mount immunofluorescence staining to detect B2 receptor protein revealed cells dis-
playing high fluorescent intensity either scattered or arranged in a cluster-like fashion in dis-
playing a low or even undetectable intensity level. This is exemplified in an image shown in
Fig 3. There was no signal detectable in smooth muscle cells in any artery studied. Control
experiments with omission of the primary antibody did not show staining of the vessel wall.
Furthermore, we never observed any significant immunofluorescence in MCAs taken from
non-occluded animals.
BK-induced relaxation after transient MCA occlusion is mediated by
release of NO and activation of an EDHF-related pathway
We studied the role of NO in mediating BK-induced relaxation after transient MCA occlusion
using 7-NI (10−6 M), a selective neuronal NOS (nNOS) inhibitor, 1400W (a selective inhibitor
Fig 2. Effects of selective bradykinin (BK) receptor antagonists on the relaxation induced by bradykinin in rat
middle cerebral artery (MCA) ring segments precontracted with U46619 (3x10-7 M). Segments were obtained 24h
following transient MCA occlusion from the ischemic side. The BK-induced relaxation was not at all affected by the
selective B1 receptor antagonist lys-(des-arg
9, leu8)-BK (10−5 M) while it was completely abrogated in the presence of
the selective B2 receptor antagonist Hoe140 (10
−6 M). Indicated are mean ± SEM based on6 observations. p<0.05,
p<0.01 vs. BK alone.
https://doi.org/10.1371/journal.pone.0198553.g002
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of the inducible NOS (iNOS), 10−6 M), and Nω–nitro-l-arginine (L-NNA, 10−6 M—10−5 M, an
unselective NOS inhibitor). While 7-NI and 1400W did not significantly affect the BK-induced
response, L-NNA inhibited relaxation in a concentration-related manner as shown in Fig 4.
Furthermore, ODQ, a selective inhibitor of the soluble guanylyl cyclase completely blocked
BK-induced relaxation. Moreover, L-NNA at 10−5 M and ODQ (10−6 M) both increased the
basal contractile force of the segments indicating involvement of the NO-cGMP pathway in
adjusting resting tension. These results suggest that NO released from the endothelial cells is of
major functional importance in the control of wall tension and mediation of BK-induced
relaxation. In accord, we found this response abrogated in endothelium-denuded segments
(results not shown).
Fig 3. Whole mount immunofluorescence staining for the expression of B2 receptors in the middle cerebral artery wall following ischemia/reperfusion injury.
Structures in blue are nuclei, while the B2 immunofluorescence presents in green. The endothelial cell nuclei run in the length axis of the artery while the smooth muscle
cell nuclei are arranged perpendicular to the endothelial cells. Filled arrows mark endothelial cells displaying high level of immunofluorescence while the empty arrow
points to an endothelial cell with low level staining. Asterisks mark smooth muscle cell nuclei (randomized choice) which are not in the focus of the image due to the
thickness of the vessel wall. The clustering of endothelial cells displaying a high level of B2 receptor immunofluorescence was a typical finding, and we never found any
immunofluorescent signal in smooth msucle cells.
https://doi.org/10.1371/journal.pone.0198553.g003
Vasomotor effects of bradykinin after I/R injury
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Although NO released from endothelial cells was identified to play a major role in mediat-
ing BK-induced relaxation following transient MCA occlusion, there is evidence in favor of a
membrane hyperpolarization-induced mechanism to be involved as well. This evidence is
based on several observations including (i) a marked decrease of the maximal relaxation
achieved with BK following precontraction in a 50 mM K+ Krebs solution as mentioned
above, and (ii) the occurrence of a transient relaxant response in the presence of 10−5 M
L-NNA (but not with 10−6 M) as shown in Fig 5 and similarly in the presence of ODQ (10−6
M) (not shown).
In order to elucidate the mechanism involved in the generation of the transient relaxant
response, we preincubated segments with different inhibitors of KCa channels before precon-
traction with U46619 and administration of BK. The results shown in Fig 6 indicate that ChTx
decreased the relaxant response to high concentrations of BK while neither apamin nor iberio-
toxin significantly affected BK-induced relaxation. In addition, ChTx increased the inhibitory
effect of L-NNA (10−6 and 10−5 M each) on the sustained phase of the BK-induced response,
but this effect did not reach statistical significance. Moreover, the transient relaxation upon
BK occurring in MCA segments with the NO-cGMP axis inhibited (see Fig 5) was completely
suppressed by ChTx. Based on the spectrum of actions with ChTx blocking large and interme-
diate conductance channels and iberiotoxin and apamin acting as selective blockers of large
Fig 4. Role of the NO-cGMP axis in bradykinin-induced relaxation in rat middle cerebral arteries obtained 24h after
induction of focal brain ischemia. Preincubation with Nω-nitro-l-arginine (L-NNA) inhibited BK-induced relaxation in a
concentration-related manner. Similarly, inhibition of the soluble guanylyl cyclase by ODQ abrogated the effect of BK. Indicated
are mean±SEM based on 4 observations.p<0.05 vs control, p<0.01 vs control.
https://doi.org/10.1371/journal.pone.0198553.g004
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and small conductance channels [26] these results strongly suggest the involvement of inter-
mediate conductance KCa channels underlying the EDHF-related pathway activated by BK.
Discussion
The present study describes a significantly enhanced relaxant action of BK in the isolated rat
MCA following transient focal brain ischemia. Enhanced relaxation was observed in MCAs
Fig 5. In the presence of Nω–nitro-l-arginine (L-NNA, 10−5 M) bradykinin (BK) elicits a transient relaxation in
middle cerebral artery segments after transient focal brain ischemia. (A) Representative trace from a segment which
was precontracted with U46619 (3x10-7 M). Application of high concentrations of BK (10−7 M to 10−5 M) induced
transient peaks of relaxation. (B) Mean values of the transient peaks of relaxation induced by high concentrations of
BK in segments obtained from the previously occluded middle cerebral artery. Indicated are mean±SEM (n = 5).
https://doi.org/10.1371/journal.pone.0198553.g005
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from the ischemic as well as from the contralateral hemisphere with the response being more
pronounced ipsilaterally. Relaxation was accompanied by a significant upregulation of the B2
and a de novo expression of the B1 mRNA in the MCA wall, again more pronounced ipsi- than
contralaterally. Whole mount immunofluorescence staining revealed the presence of B2 recep-
tor protein in previously occluded MCAs but not in arteries taken from non-occluded rats.
Relaxation was mediated by B2 activation exclusively as shown in experiments using selective
receptor antagonists. The relaxation was endothelium-dependent with release of NO playing a
major role. In addition, an EDHF-related pathway, apparently involving intermediate conduc-
tance KCa channel activation appeared to be involved as well.
In the majority of reports published, BK induced relaxation of isolated cerebral arteries
from different species including man [27–37]. However, there are also reports available on a
low efficacy or even a lack of vasodilator action of BK in rat MCAs [38, 39]. Thus, our results
in segments obtained from control rats are not at all unique. The reason for this unexpected
result in control arteries is not clear, however, endothelial damage can be excluded based on
the marked relaxation induced in all segments by the selective endothelin B receptor agonist
sarafotoxin 6c, well in line with previous observations [40]. Recent studies in our lab revealed a
moderate although significant relaxation by BK in MCAs from Wistar rats, well in accord with
data from the literature [32, 41, 42]. Thus, the lack of effect in the Sprague-Dawley rat MCAs
used in the present study is most probably a strain-specific feature. Interestingly, the B2 recep-
tor mRNA was detectable in all MCAs from control rats studied, although we could not dem-
onstrate the presence of B2 receptor protein using immunofluorescence staining. Thus, a low
level of protein expression appears to be the most feasible explanation for the lack of BK-
induced vasoactive responses in MCA segments from control rats.
In contrast to the results obtained in control arteries, BK induced marked relaxation 24h
after induction of I/R injury. This robust relaxation went along with a significant upregulation
of the B2 mRNA and a de novo expression of the B1 mRNA in the vessel wall. In this context,
Fig 6. Effects of potassium channel blockers on the relaxation induced by bradykinin (BK) in middle cerebral
artery segments after ischemia/reperfusion injury. The response to BK was partially inhibited by charybdotoxin
(ChTx, 10−8 M, n = 8), but did not change in the presence of apamin (10-7M, n = 7) or iberiotoxin (IbTx, 10−8 M,
n = 6). Indicated are mean±SEM.  p<0.01 vs. control.
https://doi.org/10.1371/journal.pone.0198553.g006
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one has to bear in mind that the MCA is not directly affected by the filament which in fact is
positioned within the internal carotid artery so as to occlude the MCA origin. Therefore, direct
mechanical disturbance/stimulation of the MCA wall as a trigger for the changes in our func-
tional and gene expression studies can well be excluded. Upregulation of the B2 and de novo
expression of the B1 receptor may be considered part of an inflammatory response, all the
more as further components of the KKS, most notably kininogen expression was also found
upregulated in the MCA following induction of I/R injury (own results). These observations
strongly suggest the presence of a complete KKS in the vascular wall implying independence
from feeding with BK or its precursor from the blood as suggested previously in a model of
focal brain injury [43]. The assumption of a vascular inflammatory response may also hold
true for the alterations seen in the contralateral MCA, although at a somewhat lower level.
These alterations may contribute to the phenomenon termed crossed hemodynamic diaschisis,
a decrease in blood flow in the contralateral cerebral and/or cerebellar hemisphere as repeat-
edly described in patients suffering from a unilateral stroke event [44, 45] and in animal exper-
iments on focal brain ischemia [46–48]. Pathophysiologically, hemodynamic diaschisis is
considered a consequence of diminished cerebral metabolism due to disturbances of neuronal
connections between the site of damage and remote regions assuming neurovascular coupling
to be intact. However, regions of hypometabolism and hypoperfusion may not necessarily
coincide [49]. Our present results suggest that endogenous reaction pathways in the vessel wall
including changes in gene expression may significantly affect control of cerebrovascular tone
and reactivity even in remote vessel sections under pathological conditions. Thus, crossed
hemodynamic diaschisis appears to be more complex than hitherto thought.
In principle, both BK receptor subtypes may be involved in the control of vasomotor tone
and blood pressure regulation [50]. However, use of selective agonists and antagonists showed
that only B2 receptor activation accounted for the relaxation-inducing effect of BK in the pres-
ent study. Thus, the functional role of B1 receptor expression in the vessel wall following I/R
injury remains obscure. The relaxation due to B2 receptor activation mainly involves the NO-
cGMP axis since it could be blocked by L-NNA and ODQ. In addition to eNOS, we also con-
sidered nNOS and iNOS as potential sources of NO release based on previous reports [51, 52].
However, neither 7-NI nor 1400W, selective inhibitors of nNOS and iNOS activity signifi-
cantly affected BK-induced relaxation suggesting eNOS to be the only functionally important
source of NO mediating BK-induced relaxation in our vessel segments. In preliminary studies
we did not find evidence in favor of an upregulation of the eNOS message in the vessel wall,
rather, the eNOS mRNA level appeared to be somewhat downregulated. Therefore, the de
novo relaxation induced by BK following induction of I/R injury appears to be due to an
increased B2 receptor expression as shown here on the level of gene expression. An increase in
receptor density will augment Ca2+ ion entry into endothelial cells upon binding of BK result-
ing in a stronger stimulation of the Ca2+-dependent eNOS activity. Moreover, the higher level
of intracellular Ca2+ concentration apparently activated a second relaxation-eliciting pathway,
apparently mediated by membrane hyperpolarization. Such a pathway has been described to
be present in many vascular beds with experimental evidence in favor of a variety of putative
factors and mechanisms depending on the species and vascular bed as reviewed recently [53,
54]. However, in many blood vessels, the increase of the intracellular Ca2+ ion concentration
following activation of a G-protein coupled receptor such as the B2 leads to activation of KCa
channels with K+ ion efflux and membrane hyperpolarization. Involvement of an EDHF-
related pathway in the present study is suggested by (i) a significantly decreased BK-induced
relaxation (approximately 50%) following precontraction with a depolarizing Krebs solution
(containing 50 mM K+) and (ii) a significantly decreased BK-induced relaxation (again
approximately 50%) following preincubation with the KCa channel blocker ChTx. The latter
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result in conjunction with the observation that neither apamin nor iberiotoxin significantly
affected BK-induced relaxation suggests that KCa channels of intermediate conductance were
activated. The presence of this KCa channel subtype in endothelial cells is well established [55].
Spread of the endothelial hyperpolarization onto the smooth muscle cells may occur via myo-
endothelial gap junctions which have been found in rat cerebral arteries [56] or the accumula-
tion of K+ ions in the interstitial space within the vessel wall with subsequent activation of the
Na/K-ATPase and inward rectifying K+ channels in the smooth muscle cells [57, 58].
The occurrence of a functionally important EDHF-related pathway in the MCA following
ischemia-reperfusion injury is in line with previous studies [53, 59]. Activation of this pathway
became apparent only when the NO-cGMP axis was inhibited and subsequently BK-induced
relaxation abrogated. Thus, an indomethacin-sensitive contribution was virtually not involved
which is in accord with previous results obtained in cerebral arteries from Sprague-Dawley
rats [60]. The appearance of an EDHF-mediated relaxation with high concentrations of BK
may be explained by data indicating that such a pathway requires a higher intraendothelial
Ca2+ concentration than eNOS stimulation [61]. In the absence of L-NNA activation of eNOS
may well have superimposed and masked the activation of the EDHF-related pathway.
In conclusion, the present study adds BK to a couple of agonists which are characterized by
altered vasomotor effects in cerebral arteries under pathological conditions such as focal ische-
mia. While these compounds including endothelin 1, angiotensin II, and serotonin have been
described to act upon the smooth muscle cells, the present study is the first to provide evidence
in favor of an altered endothelial cell function following I/R injury. The main effector appears
to be a significant upregulation of the underlying B2 receptor expression.
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